Enzyme-linked immunosorbent/chemiluminescence assays, recombinant immunoblot assays and nucleic acid tests in the diagnosis of HCV infection

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 32, Issue 8, 2013, Pages 985-988

  De Almeida Pondé, Robério Amorim ^a,b,c  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^b Central Goiana de Sorologia Imuno hematologia e Biologia Molecular   (Brazil)

^c Laboratório de Citogenética Humana e Genética Molecular LaGene   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY; VIRUS RNA;

ANTIBODY DETECTION; ANTIGEN ANTIBODY REACTION; CHEMILUMINESCENCE IMMUNOASSAY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; LABORATORY TEST; MOLECULAR DIAGNOSIS; NONHUMAN; NUCLEIC ACID AMPLIFICATION TEST; NUCLEIC ACID TEST; PRIORITY JOURNAL; RECOMBINANT IMMUNOBLOT ASSAY; REVIEW; RNA ANALYSIS; SEROLOGY; VIREMIA;

CLINICAL LABORATORY TECHNIQUES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPACIVIRUS; HEPATITIS C; HEPATITIS C, CHRONIC; HUMANS; IMMUNOBLOTTING; LUMINESCENT MEASUREMENTS; RNA, VIRAL;

EID: 84880268605     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-013-1857-1     Document Type: Review

References (22)

1. Wasley A, Alter MJ (2000) Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis 20(1):1-16
2. Feinstone SM, Kapikian AZ, Purcell RH, Alter HJ, Holland PV (1975) Transfusion-associated hepatitis not due to viral hepatitis type A or B. N Engl J Med 292(15):767-770
3. Rosen HR, Pawlotsky JM (2003) Scientific advances in hepatitis C virus. Clin Liver Dis 7:xiii-xv
4. Centers for Disease Control and Prevention (CDC) (1991) Public Health Service inter-agency guidelines for screening donors of blood, plasma, organs, tissues, and semen for evidence of hepatitis B and hepatitis C. MMWR Recomm Rep 40(RR-4):1-17
5. Pondé RA (2011) Hidden hazards of HCV transmission. Med Microbiol Immunol 200:7-11
6. Kiely P, Kay D, Parker S, Piscitelli L (2004) The significance of third-generation HCV RIBA-indeterminate, RNA-negative results in voluntary blood donors screened with sequential third-generation immunoassays. Transfusion 44(3):349-358
7. Alter M, Kuhnert WL, Finelli L; Centers for Disease Control and Prevention (2003) Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. MMWR Recomm Rep 52(RR-3):1-15
8. Alborino F, Burighel A, Tiller FW, van Helden J, Gabriel C, Raineri A, Catapano R, Stekel H (2011) Multicenter evaluation of a fully automated third-generation anti-HCV antibody screening test with excellent sensitivity and specificity. Med Microbiol Immunol 200(2):77-83
9. Kamili S, Drobeniuc J, Araujo AC, Hayden TM (2012) Laboratory diagnostics for hepatitis C virus infection. Clin Infect Dis 55(Suppl 1):S43-S48
10. Bux-Gewehr I, Schmandt S, Zotz RB, Scharf RE, Roggendorf M (2001) Long-term hepatitis C seroconversion in a blood donor. Transfusion 41(3):427
11. Wiedmann M, Kluwick S, Walter M, Fauchald G, Howe J, Bronold M, Zauke M (2007) HIV-1, HCV and HBV seronegative window reduction by the new Roche cobas TaqScreen MPX test in seroconverting donors. J Clin Virol 39:282-287
12. Tobler LH, Stramer SL, Kleinman SH, Brodsky JP, Todd DS, Busch MP (2001) Misclassification of HCV-viremic blood donors as indeterminate by RIBA 3.0 because of human superoxide dismutase reactivity. Transfusion 41:1625-1626
13. Lu SN, Tung HD, Chen TM, Lee CM, Wang JH, Hung CH, Chen CH, Changchien CS (2004) Is it possible to diagnose acute hepatitis C virus (HCV) infection by a rising anti-HCV titre rather than by seroconversion? J Viral Hepat 11(6):563-570
14. Kesli R, Ozdemir M, Kurtoglu MG, Baykan M, Baysal B (2009) Evaluation and comparison of three different anti-hepatitis C virus antibody tests based on chemiluminescence and enzyme-linked immunosorbent assay methods used in the diagnosis of hepatitis C infections in Turkey. J Int Med Res 37(5):1420-1429
15. Vernelen K, Claeys H, Verhaert H, Volckaerts A, Vermylen C (1994) Significance of NS3 and NS5 antigens in screening for HCV antibody. Lancet 343:853
16. Giachetti C, Linnen JM, Kolk DP, Dockter J, Gillotte-Taylor K, Park M, Ho-Sing-Loy M, McCormick MK, Mimms LT, McDonough SH (2002) Highly sensitive multiplex assay for detection of human immunodeficiency virus type 1 and hepatitis C virus RNA. J Clin Microbiol 7(40):2408-2419
17. Margaritis AR, Brown SM, Seed CR, Kiely P, D'Agostino B, Keller AJ (2007) Comparison of two automated nucleic acid testing systems for simultaneous detection of human immunodeficiency virus and hepatitis C virus RNA and hepatitis B virus DNA. Transfusion 47:1783-1793
18. Carreño V, Bartolomé J, Castillo I, Quiroga JÁ (2012) New perspectives in occult hepatitis C virus infection. World J Gastroenterol 18(23):2887-2894
19. Castillo I, Bartolomé J, Quiroga JA, Barril G, Carreño V (2011) Long-term virological follow up of patients with occult hepatitis C virus infection. Liver Int 31(10):1519-1524
20. Polywka S, Schröter M, Feucht HH, Zöllner B, Laufs R (2001) Relevance of reactivity in commercially available hepatitis C virus antibody assays. J Clin Microbiol 4(39):1665-1668
21. Suslov AP, Kuzin SN, Golosova TV, Shalunova NV, Malyshev NA, Sadikova NV, Vavilova LM, Somova AV, Musina EE, Ivanova MV, Kipor TT, Timonin IM, Kuzina LE, Godkov MA, Bajenov AI, Nesterenko VG (2002) Limits of diagnostic accuracy of anti-hepatitis C virus antibodies detection by ELISA and immunoblot assay. Russ J Immunol 7(2):175-184
22. Berger A, Rabenau H, Allwinn R, Doerr HW (2008) Evaluation of the new ARCHITECT anti-HCV screening test under routine laboratory conditions. J Clin Virol 43(2):158-161